Protocol for Characterizing the Inhibition of SARS-CoV-2 Infection by a Protein of Interest in Cultured Cells

Xinyuan Lai,Hui Zhuang,Tong Li,Kuanhui Xiang
DOI: https://doi.org/10.1016/j.xpro.2022.101802
2022-01-01
STAR Protocols
Abstract:Here, we present a protocol to characterize the antiviral ability of a protein of interest to SARS-CoV-2 infection in cultured cells, using MUC1 as an example. We use SARS-CoV-2 AN trVLP system, which utilizes transcription and replica-tion-competent SARS-CoV-2 virus-like particles lacking nucleocapsid gene. We describe the optimized procedure to analyze protein interference of viral attach-ment and entry into cells, and qRT-PCR-based quantification of viral infection. The protocol can be applied to characterize more antiviral candidates and clarify their functioning stage. For complete details on the use and execution of this protocol, please refer to Lai et al. (2022).
What problem does this paper attempt to address?